Efficacy and Safety of Faster-acting Insulin Aspart Compared to N

This trial is conducted globally. The aim of this trial is to investigate Efficacy and Safety of Faster-acting Insulin Aspart compared to NovoRapid® both in Combination with Insulin Degludec in Children and Adolescents with Type 1 Diabetes.

May 13, 2016